Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
A Wing, 505, Knox Plaza, Mumbai, MH, 400064, IN
Astellas gains worldwide rights to develop XNW2701 being evaluated in solid tumors, including gastric, gastroesophageal and pancreatic cancers.
This project could reduce costs in pharmaceutical development and manufacturing.
By: Rachel Klemovitch
Will add further sterile fill/finish capacity over the course of the next year.
By: Charlie Sternberg
In today’s high-stakes pharma environment, where supply chain risks, rising tariffs, and time-to-market pressures dominate, smart manufacturers are turning to a powerful but underused tool: Foreign Trade Zones (FTZs). Our latest eBook, Foreign Trade Zones in Pharma Manufacturing, reveals how FTZs are helping drug makers cut costs, streamline customs, and bring manufacturing back to U.S. soil—without compromising on quality or regulatory compliance. Whether you're a sponsor, CDMO, or supply chain leader, this guide offers insights to help you compete more efficiently in a volatile global market.
Aim to support the advancement of cutting-edge cell therapies.
Shiva Krupa also joins as Vice President of Program Management.
Acquisition supports TQ Therapeutics’ development of an ultra-short extracorporeal cell and gene therapy platform.
Helps manufacturers make informed product inspection choices through hands-on testing, real performance data, and expert support.
Collaboration combines Angelini Pharma’s global reach and focus on complex neurological disorders with GRIN’s expertise and capabilities in developing and advancing precision therapeutics for neurodevelopmental disorders.
The transaction includes STC-004, which may represent a next-generation, non-opioid treatment for chronic pain.
Aims to optimize resources and improve operational efficiency.
McCall has served as the company’s Chief Financial Officer (CFO) since 2022.
This transition reflects a planned and strategic evolution of MC2 Therapeutics, aligned with the company’s focus on commercial expansion.
The award jury recognizes strategic and sustainable corporate management.
Released By Vetter Pharma International
The approval of STARJEMZA was based on a comprehensive analytical, non-clinical, and clinical data package submitted by Bio-Thera to the FDA.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
